Home / News & Insights / Whistleblower Law Insights / Arkansas files FCA suit against Johnson & Johnson

Arkansas files FCA suit against Johnson & Johnson

Arkansas Attorney General Dustin McDaniel announced on November 20, 2007 that he has filed a suit against Johnson & Johnson Inc. and two of its subsidiaries, accusing the drug makers of illegally promoting an antipsychotic medication.

According to the Arkansas Democrat Gazette the state alleges that the drug, Risperdal, is being prescribed to treat illnesses it isn’t approved for and the manufacturers have been misrepresenting its risks to patients.

The suit was filed under the state’s Medicaid Fraud False Claims Act.

Let us help you.
Get a free, confidential case review